Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;19(8):456-61.
doi: 10.4103/0972-5229.162462.

Prognostic significance of early platelet count decline in preterm newborns

Affiliations

Prognostic significance of early platelet count decline in preterm newborns

Abeer Abd Elmoneim et al. Indian J Crit Care Med. 2015 Aug.

Abstract

Objectives: Decline of platelets with or without thrombocytopenia is observed in critically ill preterm newborns. Prognostic significance of platelets count in Neonatal Intensive Care Unit focused on outcome after thrombocytopenia. We aimed to estimate the changes in platelets count within the first 7 days of life in preterm newborns and its relation to final outcomes.

Methods: Retrospectively, the platelets count during the first 7 days of life, and its association with mortality, length of stay among survivors (LOS), and later severe morbidities were determined. Appropriate regression analyses were used to examine possible relations between studied variables.

Results and discussion: Platelets drop that did not reach thrombocytopenia level in the first 7 days of life happened in 61.7%. Platelets count drop in the first 7 days of life was a predictor of mortality, LOS, and major morbidities such as intraventricular hemorrhage and necrotizing enterocolitis.

Conclusions: Platelets count drop within the first 7 days of life independent of thrombocytopenia can be used to predict increased mortality, LOS, and the development of later severe morbidities in critically ill preterm neonates.

Keywords: Intraventricular hemorrhage; length of stay; neonatal infections; neonatal outcome; platelets; preterm; thrombocytopenia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Mortality rates in study groups
Figure 2
Figure 2
Length of stay among survivors in study groups

Similar articles

Cited by

References

    1. Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. J Pediatr. 1980;97:791–4. - PubMed
    1. Roberts I, Stanworth S, Murray NA. Thrombocytopenia in the neonate. Blood Rev. 2008;22:173–86. - PubMed
    1. Chakravorty S, Murray N, Roberts I. Neonatal thrombocytopenia. Early Hum Dev. 2005;81:35–41. - PubMed
    1. Bussel JB, Sola-Visner M. Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol. 2009;33:35–42. - PubMed
    1. Sola-Visner M, Saxonhouse MA, Brown RE. Neonatal thrombocytopenia: What we do and don't know. Early Hum Dev. 2008;84:499–506. - PubMed

LinkOut - more resources